©The Author(s) 2019.
World J Gastroenterol. May 21, 2019; 25(19): 2338-2353
Published online May 21, 2019. doi: 10.3748/wjg.v25.i19.2338
Published online May 21, 2019. doi: 10.3748/wjg.v25.i19.2338
Table 1 Characteristics of the patients at baseline
| Variable | ≥ 60 yr old | < 60 yr old |
| Gender | ||
| Male | 21 (91.3) | 18 (72.0) |
| Female | 2 (8.7) | 7 (28.0) |
| Tumor location | ||
| Lower | 2 (8.7) | 4 (16.0) |
| Middle | 9 (39.1) | 12 (48.0) |
| Upper | 12 (52.2) | 9 (36.0) |
| Clinical tumor stage | ||
| T4 | 22 (95.7) | 23 (92.0) |
| T3 | 1 (4.3) | 2 (8.0) |
| Clinical nodal stage | ||
| N2-3 | 18 (78.3) | 21 (84.0) |
| N0-1 | 5 (21.7) | 4 (16.0) |
| Macroscopic type | ||
| 4 | 4 (17.4) | 3 (12.0) |
| 1-3 or 5 | 19 (82.6) | 22 (88.0) |
| Differentiation | ||
| Poorly differentiated | 18 (78.3) | 23 (92.0) |
| Well differentiated | 5 (21.7) | 2 (8.0) |
| Performance status | ||
| 0 | 6 (26.1) | 11 (44.0) |
| 1 | 17 (73.9) | 14 (56.0) |
- Citation: Zheng XH, Zhang W, Yang L, Du CX, Li N, Xing GS, Tian YT, Xie YB. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis. World J Gastroenterol 2019; 25(19): 2338-2353
- URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2338.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i19.2338